• Featured Product
  • KD/KO Validated

ATP6V0A4 Polyklonaler Antikörper

ATP6V0A4 Polyklonal Antikörper für IHC, WB,ELISA

Wirt / Isotyp

Kaninchen / IgG

Getestete Reaktivität

human, Maus

Anwendung

WB, IHC, ELISA

Konjugation

Unkonjugiert

Kat-Nr. : 21570-1-AP

Synonyme

A4, ATP6N1B, ATP6N2, ATP6V0A4, RDRTA2, RTA1C, RTADR, STV1, V ATPase 116 kDa isoform a4, VPH1, VPP2



Geprüfte Anwendungen

Erfolgreiche Detektion in WBMausnierengewebe
Erfolgreiche Detektion in IHChumanes Nierengewebe
Hinweis: Antigendemaskierung mit TE-Puffer pH 9,0 empfohlen. (*) Wahlweise kann die Antigendemaskierung auch mit Citratpuffer pH 6,0 erfolgen.

Empfohlene Verdünnung

AnwendungVerdünnung
Western Blot (WB)WB : 1:500-1:2000
Immunhistochemie (IHC)IHC : 1:50-1:500
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, check data in validation data gallery

Veröffentlichte Anwendungen

IHCSee 1 publications below

Produktinformation

21570-1-AP bindet in WB, IHC, ELISA ATP6V0A4 und zeigt Reaktivität mit human, Maus

Getestete Reaktivität human, Maus
In Publikationen genannte Reaktivitäthuman
Wirt / Isotyp Kaninchen / IgG
Klonalität Polyklonal
Typ Antikörper
Immunogen ATP6V0A4 fusion protein Ag16095
Vollständiger Name ATPase, H+ transporting, lysosomal V0 subunit a4
Berechnetes Molekulargewicht 840 aa, 96 kDa
Beobachtetes Molekulargewicht100 kDa
GenBank-ZugangsnummerBC109305
Gene symbol ATP6V0A4
Gene ID (NCBI) 50617
Konjugation Unkonjugiert
Form Liquid
Reinigungsmethode Antigen-Affinitätsreinigung
Lagerungspuffer PBS mit 0.02% Natriumazid und 50% Glycerin pH 7.3.
LagerungsbedingungenBei -20°C lagern. Nach dem Versand ein Jahr lang stabil Aliquotieren ist bei -20oC Lagerung nicht notwendig. 20ul Größen enthalten 0,1% BSA.

Hintergrundinformationen

The ATP6V0A4 is a component of vacuolar-H+ATPase (V-ATPase) which is a multi-subunit enzyme that couples ATP hydrolysis to proton pumping across membranes. The V-ATPases are comprised of two major parts, the cytosolic V1 domain involved in ATP-binding and subsequent hydrolysis, and the membrane-associated V0 domain responsible for proton translocation. The V0 domain is composed of five subunits: a, c, c', c'' and d. The 'a' subunit of V0 domain has four isoforms : a1-a4. It has been found that mutations in ATP6V0A4(a4) are associated with distal renal tubular acidosis(dRTA) combined in some cases with progressive hearing loss leading to sensorineural deafness. This antibody was generated against the internal region of human ATP6V0A4 and is predicted to detect the a4 isoform only.

Protokolle

Produktspezifische Protokolle
WB protocol for ATP6V0A4 antibody 21570-1-APProtokoll herunterladen
IHC protocol for ATP6V0A4 antibody 21570-1-APProtokoll herunterladen
Standard-Protokolle
Klicken Sie hier, um unsere Standardprotokolle anzuzeigen

Publikationen

SpeciesApplicationTitle
humanIHC

Oncol Lett

Identification of ATP6V0A4 as a potential biomarker in renal cell carcinoma using integrated bioinformatics analysis

Authors - Jinming Xu

Rezensionen

The reviews below have been submitted by verified Proteintech customers who received an incentive forproviding their feedback.


FH

Christopher (Verified Customer) (12-14-2020)

We used the anti-ATP6V0A4 antibody. In lysates of homozygous Atp6v0a4-KO mice (described in Hennings et al., EMBO Mol Med, 2012) the signal for ATP6V0A4 was not detected anymore. Thus, the antibody is specific and does not cross-react.

  • Applications: Western Blot
  • Primary Antibody Dilution: 1:1000
  • Cell Tissue Type: Kidney lysate, IN-IC and HK-2 cells
ATP6V0A4 Antibody Western Blot validation (1:1000 dilution) in Kidney lysate, IN-IC and HK-2 cells (Cat no:21570-1-AP)